PFAS fireside chats
What remains in our soil
Tony Whetton shows us that precision medicine is both our present and our future. He presents a new strategy for the treatment of leukemia that could move the dial from effective management toward a cure.
19 / 04 / 2022 | Anthony Whetton
The best possible treatment for an individual patient is the definition of precision medicine. Tony Whetton discusses this approach in the context of chronic myeloid leukemia. He explains how proteomics, mass spectrometry and informatics can help scientists figure out how to destroy myeloid stem cells. A focus on two drug targets is the proposed path to a curative strategy, instead of following the current practice of disease management.
Anthony Whetton, PhD
Professor of Translational Biosystems
University of Surrey
Emeritus Professor
University of Manchester
View profile